$1.7 Million NIH Grant to Fund Pain Therapeutics’ Study of PTI-125 as Candidate for Alzheimer’s Treatment

$1.7 Million NIH Grant to Fund Pain Therapeutics’ Study of PTI-125 as Candidate for Alzheimer’s Treatment
The National Institutes of Health (NIH) has awarded Pain Therapeutics a $1.7 million research grant to study PTI-125 as a potential treatment for Alzheimer’s disease. PTI-125 is an oral, small molecule drug developed by the Austin, Texas-based company in collaboration with other partners. It has been shown to significantly improve Alzheimer’s neurodegeneration in animal models of the

Knowledge is power when living with alzheimers.

Get access to the web’s leading Alzheimer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

One comment

Leave a Comment

Your email address will not be published. Required fields are marked *